Is a chewable form of methylphenidate available for the treatment of attention deficit hyperactivity disorder (ADHD)?

Updated: Nov 20, 2018
  • Author: Maggie A Wilkes, MD; Chief Editor: Caroly Pataki, MD  more...
  • Print
Answer

In December 2015, the FDA approved a chewable tablet form of extended-release methylphenidate, to be sold as QuilliChew ER, for treatment of ADHD in patients aged 6 years or older. The tablet comes in strengths of 20, 30, and 40 mg and are scored so they can be split easily. The product is to be taken once daily in the morning. [13]


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!